nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—CYP3A4—Rosuvastatin—atherosclerosis	0.119	0.211	CbGbCtD
Sufentanil—CYP3A4—Ezetimibe—atherosclerosis	0.119	0.211	CbGbCtD
Sufentanil—CYP3A4—Simvastatin—atherosclerosis	0.111	0.196	CbGbCtD
Sufentanil—CYP3A4—Lovastatin—atherosclerosis	0.108	0.192	CbGbCtD
Sufentanil—CYP3A4—Pravastatin—atherosclerosis	0.108	0.192	CbGbCtD
Sufentanil—Laryngospasm—Niacin—atherosclerosis	0.00906	0.0476	CcSEcCtD
Sufentanil—Urinary retention—Niacin—atherosclerosis	0.00467	0.0245	CcSEcCtD
Sufentanil—Arrhythmia—Rosuvastatin—atherosclerosis	0.00417	0.0219	CcSEcCtD
Sufentanil—Chills—Lovastatin—atherosclerosis	0.00355	0.0187	CcSEcCtD
Sufentanil—Erythema—Ezetimibe—atherosclerosis	0.00338	0.0177	CcSEcCtD
Sufentanil—Confusional state—Rosuvastatin—atherosclerosis	0.00334	0.0176	CcSEcCtD
Sufentanil—Chills—Simvastatin—atherosclerosis	0.00332	0.0174	CcSEcCtD
Sufentanil—Erythema—Simvastatin—atherosclerosis	0.00322	0.0169	CcSEcCtD
Sufentanil—Chills—Niacin—atherosclerosis	0.00305	0.016	CcSEcCtD
Sufentanil—Arrhythmia—Niacin—atherosclerosis	0.00303	0.0159	CcSEcCtD
Sufentanil—Chills—Pravastatin—atherosclerosis	0.003	0.0158	CcSEcCtD
Sufentanil—Arrhythmia—Pravastatin—atherosclerosis	0.00299	0.0157	CcSEcCtD
Sufentanil—Erythema—Niacin—atherosclerosis	0.00296	0.0155	CcSEcCtD
Sufentanil—Hypertension—Ezetimibe—atherosclerosis	0.00291	0.0153	CcSEcCtD
Sufentanil—Confusional state—Lovastatin—atherosclerosis	0.00283	0.0149	CcSEcCtD
Sufentanil—Anaphylactic shock—Lovastatin—atherosclerosis	0.00281	0.0148	CcSEcCtD
Sufentanil—Confusional state—Ezetimibe—atherosclerosis	0.00278	0.0146	CcSEcCtD
Sufentanil—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00276	0.0145	CcSEcCtD
Sufentanil—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00273	0.0144	CcSEcCtD
Sufentanil—Confusional state—Simvastatin—atherosclerosis	0.00265	0.0139	CcSEcCtD
Sufentanil—Anaphylactic shock—Simvastatin—atherosclerosis	0.00263	0.0138	CcSEcCtD
Sufentanil—Hypertension—Pravastatin—atherosclerosis	0.00251	0.0132	CcSEcCtD
Sufentanil—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00244	0.0128	CcSEcCtD
Sufentanil—Anaphylactic shock—Niacin—atherosclerosis	0.00241	0.0127	CcSEcCtD
Sufentanil—Confusional state—Pravastatin—atherosclerosis	0.0024	0.0126	CcSEcCtD
Sufentanil—Anaphylactic shock—Pravastatin—atherosclerosis	0.00238	0.0125	CcSEcCtD
Sufentanil—Tachycardia—Niacin—atherosclerosis	0.00235	0.0124	CcSEcCtD
Sufentanil—Pruritus—Rosuvastatin—atherosclerosis	0.00235	0.0123	CcSEcCtD
Sufentanil—Feeling abnormal—Lovastatin—atherosclerosis	0.00232	0.0122	CcSEcCtD
Sufentanil—Feeling abnormal—Ezetimibe—atherosclerosis	0.00227	0.0119	CcSEcCtD
Sufentanil—Hypotension—Niacin—atherosclerosis	0.00225	0.0119	CcSEcCtD
Sufentanil—Body temperature increased—Lovastatin—atherosclerosis	0.00222	0.0117	CcSEcCtD
Sufentanil—Dizziness—Rosuvastatin—atherosclerosis	0.00219	0.0115	CcSEcCtD
Sufentanil—Body temperature increased—Ezetimibe—atherosclerosis	0.00218	0.0115	CcSEcCtD
Sufentanil—Feeling abnormal—Simvastatin—atherosclerosis	0.00217	0.0114	CcSEcCtD
Sufentanil—Somnolence—Niacin—atherosclerosis	0.00214	0.0113	CcSEcCtD
Sufentanil—Rash—Rosuvastatin—atherosclerosis	0.00209	0.011	CcSEcCtD
Sufentanil—Dermatitis—Rosuvastatin—atherosclerosis	0.00209	0.011	CcSEcCtD
Sufentanil—Body temperature increased—Simvastatin—atherosclerosis	0.00208	0.0109	CcSEcCtD
Sufentanil—Headache—Rosuvastatin—atherosclerosis	0.00208	0.0109	CcSEcCtD
Sufentanil—Hypersensitivity—Lovastatin—atherosclerosis	0.00207	0.0109	CcSEcCtD
Sufentanil—Hypersensitivity—Ezetimibe—atherosclerosis	0.00203	0.0107	CcSEcCtD
Sufentanil—Pruritus—Lovastatin—atherosclerosis	0.00199	0.0104	CcSEcCtD
Sufentanil—Nausea—Rosuvastatin—atherosclerosis	0.00197	0.0104	CcSEcCtD
Sufentanil—Feeling abnormal—Pravastatin—atherosclerosis	0.00196	0.0103	CcSEcCtD
Sufentanil—Pruritus—Ezetimibe—atherosclerosis	0.00195	0.0102	CcSEcCtD
Sufentanil—Hypersensitivity—Simvastatin—atherosclerosis	0.00194	0.0102	CcSEcCtD
Sufentanil—Body temperature increased—Niacin—atherosclerosis	0.00191	0.01	CcSEcCtD
Sufentanil—Body temperature increased—Pravastatin—atherosclerosis	0.00188	0.00987	CcSEcCtD
Sufentanil—Pruritus—Simvastatin—atherosclerosis	0.00186	0.00977	CcSEcCtD
Sufentanil—Dizziness—Lovastatin—atherosclerosis	0.00186	0.00977	CcSEcCtD
Sufentanil—Dizziness—Ezetimibe—atherosclerosis	0.00182	0.00958	CcSEcCtD
Sufentanil—Vomiting—Lovastatin—atherosclerosis	0.00179	0.00939	CcSEcCtD
Sufentanil—Hypersensitivity—Niacin—atherosclerosis	0.00178	0.00934	CcSEcCtD
Sufentanil—Rash—Lovastatin—atherosclerosis	0.00177	0.00931	CcSEcCtD
Sufentanil—Dermatitis—Lovastatin—atherosclerosis	0.00177	0.0093	CcSEcCtD
Sufentanil—Headache—Lovastatin—atherosclerosis	0.00176	0.00925	CcSEcCtD
Sufentanil—Vomiting—Ezetimibe—atherosclerosis	0.00175	0.00921	CcSEcCtD
Sufentanil—Hypersensitivity—Pravastatin—atherosclerosis	0.00175	0.0092	CcSEcCtD
Sufentanil—Dizziness—Simvastatin—atherosclerosis	0.00174	0.00913	CcSEcCtD
Sufentanil—Rash—Ezetimibe—atherosclerosis	0.00174	0.00913	CcSEcCtD
Sufentanil—Dermatitis—Ezetimibe—atherosclerosis	0.00174	0.00912	CcSEcCtD
Sufentanil—Headache—Ezetimibe—atherosclerosis	0.00173	0.00907	CcSEcCtD
Sufentanil—Pruritus—Niacin—atherosclerosis	0.00171	0.00897	CcSEcCtD
Sufentanil—Pruritus—Pravastatin—atherosclerosis	0.00168	0.00884	CcSEcCtD
Sufentanil—Vomiting—Simvastatin—atherosclerosis	0.00167	0.00878	CcSEcCtD
Sufentanil—Nausea—Lovastatin—atherosclerosis	0.00167	0.00877	CcSEcCtD
Sufentanil—Rash—Simvastatin—atherosclerosis	0.00166	0.00871	CcSEcCtD
Sufentanil—Dermatitis—Simvastatin—atherosclerosis	0.00166	0.0087	CcSEcCtD
Sufentanil—Headache—Simvastatin—atherosclerosis	0.00165	0.00865	CcSEcCtD
Sufentanil—Nausea—Ezetimibe—atherosclerosis	0.00164	0.0086	CcSEcCtD
Sufentanil—Dizziness—Niacin—atherosclerosis	0.0016	0.00839	CcSEcCtD
Sufentanil—Dizziness—Pravastatin—atherosclerosis	0.00157	0.00826	CcSEcCtD
Sufentanil—Nausea—Simvastatin—atherosclerosis	0.00156	0.0082	CcSEcCtD
Sufentanil—Vomiting—Niacin—atherosclerosis	0.00153	0.00806	CcSEcCtD
Sufentanil—Rash—Niacin—atherosclerosis	0.00152	0.008	CcSEcCtD
Sufentanil—Dermatitis—Niacin—atherosclerosis	0.00152	0.00799	CcSEcCtD
Sufentanil—Headache—Niacin—atherosclerosis	0.00151	0.00795	CcSEcCtD
Sufentanil—Vomiting—Pravastatin—atherosclerosis	0.00151	0.00794	CcSEcCtD
Sufentanil—Rash—Pravastatin—atherosclerosis	0.0015	0.00787	CcSEcCtD
Sufentanil—Dermatitis—Pravastatin—atherosclerosis	0.0015	0.00787	CcSEcCtD
Sufentanil—Headache—Pravastatin—atherosclerosis	0.00149	0.00782	CcSEcCtD
Sufentanil—Nausea—Niacin—atherosclerosis	0.00143	0.00753	CcSEcCtD
Sufentanil—Nausea—Pravastatin—atherosclerosis	0.00141	0.00742	CcSEcCtD
Sufentanil—OPRD1—Signaling Pathways—LDLR—atherosclerosis	0.000167	0.000684	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CNR2—atherosclerosis	0.000167	0.000681	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CXCL8—atherosclerosis	0.000167	0.000681	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—MMP3—atherosclerosis	0.000166	0.00068	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—APOA2—atherosclerosis	0.000166	0.000677	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—AGT—atherosclerosis	0.000165	0.000674	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000164	0.000672	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCL3—atherosclerosis	0.000163	0.000668	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—KNG1—atherosclerosis	0.000159	0.000648	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—EDN1—atherosclerosis	0.000158	0.000646	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—UTS2—atherosclerosis	0.000158	0.000646	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	0.000158	0.000645	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—AGTR1—atherosclerosis	0.000158	0.000644	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCL5—atherosclerosis	0.000157	0.000641	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NCF1—atherosclerosis	0.000157	0.00064	CbGpPWpGaD
Sufentanil—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	0.000156	0.000636	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—F2—atherosclerosis	0.000152	0.000623	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CX3CR1—atherosclerosis	0.000152	0.000619	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CASR—atherosclerosis	0.000152	0.000619	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—AGT—atherosclerosis	0.00015	0.000612	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PRKCG—atherosclerosis	0.000149	0.00061	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CX3CL1—atherosclerosis	0.000149	0.000607	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—VWF—atherosclerosis	0.000149	0.000607	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCR2—atherosclerosis	0.000148	0.000604	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EDNRA—atherosclerosis	0.000148	0.000604	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—APOC3—atherosclerosis	0.000148	0.000603	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—EDN1—atherosclerosis	0.000147	0.000602	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CYBA—atherosclerosis	0.000147	0.000602	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—LDLR—atherosclerosis	0.000147	0.0006	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CCL5—atherosclerosis	0.000146	0.000597	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000146	0.000596	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—AGT—atherosclerosis	0.000145	0.000591	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PLAT—atherosclerosis	0.000144	0.000589	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PARP1—atherosclerosis	0.000144	0.000589	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—GHRL—atherosclerosis	0.000144	0.000589	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCL3—atherosclerosis	0.000143	0.000586	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CNR2—atherosclerosis	0.000141	0.000576	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CXCL8—atherosclerosis	0.000141	0.000575	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—MMP3—atherosclerosis	0.000141	0.000574	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000139	0.000568	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—F2—atherosclerosis	0.000138	0.000565	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NCF1—atherosclerosis	0.000137	0.000561	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—EDN1—atherosclerosis	0.000134	0.000546	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—F2—atherosclerosis	0.000134	0.000546	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCL5—atherosclerosis	0.000133	0.000542	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000132	0.000541	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—AGT—atherosclerosis	0.000131	0.000537	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EDNRA—atherosclerosis	0.00013	0.00053	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCR2—atherosclerosis	0.00013	0.00053	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CYBA—atherosclerosis	0.000129	0.000527	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000128	0.000523	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—KNG1—atherosclerosis	0.000126	0.000517	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—GHRL—atherosclerosis	0.000126	0.000516	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PLAT—atherosclerosis	0.000126	0.000516	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PARP1—atherosclerosis	0.000126	0.000516	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PRKCG—atherosclerosis	0.000126	0.000515	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AGTR1—atherosclerosis	0.000126	0.000514	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—VWF—atherosclerosis	0.000126	0.000513	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—APOC3—atherosclerosis	0.000125	0.00051	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—LDLR—atherosclerosis	0.000124	0.000507	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CCL2—atherosclerosis	0.000123	0.000504	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PLG—atherosclerosis	0.000123	0.000501	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—AGT—atherosclerosis	0.000122	0.000499	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—F2—atherosclerosis	0.000121	0.000496	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCL3—atherosclerosis	0.000121	0.000495	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000116	0.000474	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NCF1—atherosclerosis	0.000116	0.000474	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SOCS3—atherosclerosis	0.000116	0.000474	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—F2—atherosclerosis	0.000113	0.000461	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MMP3—atherosclerosis	0.000112	0.000458	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	0.000112	0.000457	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IGF2—atherosclerosis	0.000112	0.000456	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—AGT—atherosclerosis	0.000111	0.000454	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KNG1—atherosclerosis	0.000111	0.000453	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AGTR1—atherosclerosis	0.00011	0.00045	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCR2—atherosclerosis	0.00011	0.000448	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EDNRA—atherosclerosis	0.00011	0.000448	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CYBA—atherosclerosis	0.000109	0.000446	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—APOB—atherosclerosis	0.000108	0.000443	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCL2—atherosclerosis	0.000108	0.000442	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000108	0.000442	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PLG—atherosclerosis	0.000107	0.000439	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000107	0.000439	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—GHRL—atherosclerosis	0.000107	0.000436	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PLAT—atherosclerosis	0.000107	0.000436	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PARP1—atherosclerosis	0.000107	0.000436	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EDN1—atherosclerosis	0.000107	0.000436	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCL5—atherosclerosis	0.000106	0.000432	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PLTP—atherosclerosis	0.000105	0.00043	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—LPL—atherosclerosis	0.000103	0.000423	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—F2—atherosclerosis	0.000103	0.000419	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SOCS3—atherosclerosis	0.000102	0.000416	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PRKCG—atherosclerosis	0.000101	0.000411	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MMP3—atherosclerosis	9.83e-05	0.000401	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3CG—atherosclerosis	9.81e-05	0.000401	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SPP1—atherosclerosis	9.79e-05	0.0004	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IGF2—atherosclerosis	9.78e-05	0.0004	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CXCL8—atherosclerosis	9.75e-05	0.000398	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—APOB—atherosclerosis	9.5e-05	0.000388	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CXCL8—atherosclerosis	9.42e-05	0.000385	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KNG1—atherosclerosis	9.37e-05	0.000383	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EDN1—atherosclerosis	9.35e-05	0.000382	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AGTR1—atherosclerosis	9.32e-05	0.000381	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCL5—atherosclerosis	9.27e-05	0.000379	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCL2—atherosclerosis	9.14e-05	0.000373	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—LTA4H—atherosclerosis	9.12e-05	0.000373	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ABCG8—atherosclerosis	9.12e-05	0.000373	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PLG—atherosclerosis	9.08e-05	0.000371	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—LPL—atherosclerosis	9.07e-05	0.000371	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PDGFB—atherosclerosis	9.06e-05	0.00037	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AGT—atherosclerosis	8.85e-05	0.000361	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PRKCG—atherosclerosis	8.82e-05	0.00036	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—LEP—atherosclerosis	8.67e-05	0.000354	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—APOE—atherosclerosis	8.67e-05	0.000354	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SOCS3—atherosclerosis	8.6e-05	0.000351	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SPP1—atherosclerosis	8.59e-05	0.000351	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CAV1—atherosclerosis	8.59e-05	0.000351	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—APOA1—atherosclerosis	8.57e-05	0.00035	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CXCL8—atherosclerosis	8.55e-05	0.000349	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MMP3—atherosclerosis	8.3e-05	0.000339	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ESR1—atherosclerosis	8.28e-05	0.000338	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IGF2—atherosclerosis	8.27e-05	0.000338	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—F2—atherosclerosis	8.17e-05	0.000334	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—APOB—atherosclerosis	8.03e-05	0.000328	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CXCL8—atherosclerosis	7.96e-05	0.000325	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PDGFB—atherosclerosis	7.95e-05	0.000325	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EDN1—atherosclerosis	7.9e-05	0.000323	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCL5—atherosclerosis	7.84e-05	0.00032	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CG—atherosclerosis	7.82e-05	0.00032	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AGT—atherosclerosis	7.76e-05	0.000317	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—LPL—atherosclerosis	7.66e-05	0.000313	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—LEP—atherosclerosis	7.6e-05	0.000311	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—APOE—atherosclerosis	7.6e-05	0.000311	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CAV1—atherosclerosis	7.53e-05	0.000308	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—APOA1—atherosclerosis	7.51e-05	0.000307	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—MAPK3—atherosclerosis	7.49e-05	0.000306	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PRKCG—atherosclerosis	7.45e-05	0.000304	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—INS—atherosclerosis	7.4e-05	0.000303	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCL2—atherosclerosis	7.29e-05	0.000298	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SPP1—atherosclerosis	7.26e-05	0.000297	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ESR1—atherosclerosis	7.26e-05	0.000297	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CXCL8—atherosclerosis	7.23e-05	0.000295	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ABCG1—atherosclerosis	7.21e-05	0.000295	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—F2—atherosclerosis	7.17e-05	0.000293	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IGF1—atherosclerosis	7.16e-05	0.000293	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CG—atherosclerosis	6.86e-05	0.00028	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SERPINE1—atherosclerosis	6.8e-05	0.000278	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—FABP4—atherosclerosis	6.78e-05	0.000277	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—LCAT—atherosclerosis	6.78e-05	0.000277	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PDGFB—atherosclerosis	6.72e-05	0.000274	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOA4—atherosclerosis	6.65e-05	0.000272	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—MAPK3—atherosclerosis	6.57e-05	0.000268	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AGT—atherosclerosis	6.56e-05	0.000268	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP7A1—atherosclerosis	6.54e-05	0.000267	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NOS3—atherosclerosis	6.49e-05	0.000265	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—INS—atherosclerosis	6.49e-05	0.000265	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—LEP—atherosclerosis	6.42e-05	0.000262	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—APOE—atherosclerosis	6.42e-05	0.000262	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCL2—atherosclerosis	6.39e-05	0.000261	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CAV1—atherosclerosis	6.36e-05	0.00026	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—APOA1—atherosclerosis	6.35e-05	0.000259	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IGF1—atherosclerosis	6.28e-05	0.000257	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ESR1—atherosclerosis	6.13e-05	0.000251	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—F2—atherosclerosis	6.06e-05	0.000248	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP27A1—atherosclerosis	6.04e-05	0.000247	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SERPINE1—atherosclerosis	5.96e-05	0.000244	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CG—atherosclerosis	5.8e-05	0.000237	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CXCL8—atherosclerosis	5.76e-05	0.000235	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	5.73e-05	0.000234	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	5.73e-05	0.000234	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOA2—atherosclerosis	5.73e-05	0.000234	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALOX15—atherosclerosis	5.73e-05	0.000234	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NOS3—atherosclerosis	5.69e-05	0.000233	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ABCG5—atherosclerosis	5.66e-05	0.000231	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—AKT1—atherosclerosis	5.56e-05	0.000227	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—MAPK3—atherosclerosis	5.55e-05	0.000227	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—INS—atherosclerosis	5.49e-05	0.000224	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL6—atherosclerosis	5.48e-05	0.000224	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—LPA—atherosclerosis	5.46e-05	0.000223	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCL2—atherosclerosis	5.4e-05	0.000221	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IGF1—atherosclerosis	5.31e-05	0.000217	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—BGN—atherosclerosis	5.29e-05	0.000216	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOA5—atherosclerosis	5.24e-05	0.000214	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MMP9—atherosclerosis	5.21e-05	0.000213	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NFKB1—atherosclerosis	5.15e-05	0.000211	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MAPK8—atherosclerosis	5.07e-05	0.000207	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—AKT1—atherosclerosis	5.05e-05	0.000206	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CXCL8—atherosclerosis	5.05e-05	0.000206	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	5.04e-05	0.000206	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SERPINE1—atherosclerosis	5.04e-05	0.000206	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—AKT1—atherosclerosis	4.88e-05	0.000199	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALOX5—atherosclerosis	4.87e-05	0.000199	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NOS3—atherosclerosis	4.81e-05	0.000197	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL6—atherosclerosis	4.8e-05	0.000196	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—VEGFA—atherosclerosis	4.68e-05	0.000191	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—STAT3—atherosclerosis	4.63e-05	0.000189	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MMP9—atherosclerosis	4.57e-05	0.000187	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NFKB1—atherosclerosis	4.52e-05	0.000185	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MAPK8—atherosclerosis	4.44e-05	0.000182	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—AKT1—atherosclerosis	4.43e-05	0.000181	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MAPK3—atherosclerosis	4.43e-05	0.000181	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NAMPT—atherosclerosis	4.37e-05	0.000178	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—LIPC—atherosclerosis	4.34e-05	0.000177	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOC3—atherosclerosis	4.31e-05	0.000176	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TGFB1—atherosclerosis	4.29e-05	0.000175	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—LDLR—atherosclerosis	4.29e-05	0.000175	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCL8—atherosclerosis	4.27e-05	0.000174	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CETP—atherosclerosis	4.19e-05	0.000171	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—AKT1—atherosclerosis	4.12e-05	0.000169	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—VEGFA—atherosclerosis	4.1e-05	0.000168	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—STAT3—atherosclerosis	4.06e-05	0.000166	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL6—atherosclerosis	4.06e-05	0.000166	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SCARB1—atherosclerosis	4.01e-05	0.000164	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MAPK3—atherosclerosis	3.88e-05	0.000159	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MMP9—atherosclerosis	3.86e-05	0.000158	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NFKB1—atherosclerosis	3.82e-05	0.000156	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HMGCR—atherosclerosis	3.79e-05	0.000155	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TGFB1—atherosclerosis	3.77e-05	0.000154	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MAPK8—atherosclerosis	3.76e-05	0.000153	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—AKT1—atherosclerosis	3.74e-05	0.000153	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—VEGFA—atherosclerosis	3.47e-05	0.000142	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—STAT3—atherosclerosis	3.43e-05	0.00014	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ABCA1—atherosclerosis	3.38e-05	0.000138	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MAPK3—atherosclerosis	3.28e-05	0.000134	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL6—atherosclerosis	3.24e-05	0.000132	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TGFB1—atherosclerosis	3.18e-05	0.00013	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AKT1—atherosclerosis	2.98e-05	0.000122	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.9e-05	0.000118	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL6—atherosclerosis	2.84e-05	0.000116	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOB—atherosclerosis	2.77e-05	0.000113	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.7e-05	0.00011	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—LPL—atherosclerosis	2.65e-05	0.000108	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AKT1—atherosclerosis	2.62e-05	0.000107	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GPX1—atherosclerosis	2.58e-05	0.000106	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CD36—atherosclerosis	2.52e-05	0.000103	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL6—atherosclerosis	2.4e-05	9.8e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.38e-05	9.75e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PPARA—atherosclerosis	2.34e-05	9.56e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AGT—atherosclerosis	2.27e-05	9.26e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOE—atherosclerosis	2.22e-05	9.07e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AKT1—atherosclerosis	2.21e-05	9.04e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CAV1—atherosclerosis	2.2e-05	8.99e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOA1—atherosclerosis	2.19e-05	8.97e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2e-05	8.19e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PPARG—atherosclerosis	1.93e-05	7.9e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—INS—atherosclerosis	1.9e-05	7.75e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALB—atherosclerosis	1.74e-05	7.11e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NOS3—atherosclerosis	1.66e-05	6.8e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.52e-05	6.22e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AKT1—atherosclerosis	7.65e-06	3.12e-05	CbGpPWpGaD
